SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-19-000460
Filing Date
2019-02-01
Accepted
2019-02-01 18:47:35
Documents
2
Period of Report
2019-01-23

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 2719
2 POWER OF ATTORNEY exhibit24.htm EX-24 6184
  Complete submission text file 0001062993-19-000460.txt   10252
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 23733 N. LOOKOUT PT. ROAD LAKE BARRINGTON IL 60010
Business Address
Law Ronald Edward (Reporting) CIK: 0001701348 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34236 | Film No.: 19561256